We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-4 of 4

New FDA draft guidance on mobile medical apps provides some clarity, but raises many more questions
  • Morgan Lewis
  • USA
  • July 28 2011

On July 19, the Food and Drug Administration (FDA) issued a new draft guidance document, titled Mobile Medical Applications, describing FDA’s position on the regulation of mobile applications, i.e., software applications intended to run on mobile platforms, such as smart phones, personal digital assistants, tablets, and other mobile computing devices.

IRS requests comments on new medical device excise tax
  • Morgan Lewis
  • USA
  • December 3 2010

The Internal Revenue Service (IRS) issued a notice today inviting public comments on issues that the IRS should address in its guidance for the implementation of the new medical device excise tax imposed under the Health Care and Education Reconciliation Act of 2010 (Pub. L. No. 111-152).